# Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions

> **NCT02802553** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Invasive Breast Cancer

## Interventions

- **DEVICE:** Smart Goggle
- **OTHER:** Cardio-Green
- **DEVICE:** SPY Elite Imaging system
- **DEVICE:** Quest near-infrared (NIR) Imaging system
- **DEVICE:** PDE Imaging system
- **DEVICE:** Gamma probe
- **OTHER:** Blue Dyes

## Key facts

- **NCT ID:** NCT02802553
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-28
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02802553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02802553, "Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02802553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*